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a  b  s  t  r  a  c  t
Background:  A vast  diversity  in rotaviruses  at  inter-  and  intra-genotypic  level  underscores  the need  for
monitoring  of  circulating  rotavirus  strains.  The  aim of this  study  was to  update  the  data  on  rotavirus
disease  and  strains  for the  period  from  January  2009  to  December  2012  in  Pune, western  India  which  has
been  one  of  the  sites  of  the  Indian  Rotavirus  Strain  Surveillance  Network  since  November  2005.
Methods:  Children  aged  <5 years  admitted  for  acute  gastroenteritis  in  three different  hospitals  from
Pune  city  were  included  in the  study.  The  stool  specimens  were  collected  and  tested  for  rotavirus  anti-
gen  by  a commercial  enzyme  immunoassay.  The  rotavirus  strains  were  genotyped  by multiplex  reverse
transcription  polymerase  chain  reaction.
Results:  During  the  study  period,  we found  35.1%  of  685  stool  specimens  contained  rotavirus  antigen.
Frequency  of  rotavirus  detection  was  greatest  (58.5%)  among  children  aged  7–12  months.  The  G1P[8]
(31.4%),  G2P[4]  (20.2%)  and  G9P[8]  (11.8%)  strains  were  the  most  common  types.  We noted  predominance
of  G1P[8]  strains  (39.6%-46.1%)  in  all the  years  of  study  except  2009  wherein  G9P[8]  strains  scored  highest
level  (15.3%).  Subsequent  to this,  we  identiﬁed  G9P[8]  strains  at the  second  highest  position  in  2010,  their
sudden  decline  and  rise in  G9P[4]  strains  in 2011–2012.  We  detected  G12  strains  in combination  with
P[6]  and  P[8]  at  variable  rates  (0–10.2%)  and  highest  level  (27.1%)  of  mixed  rotavirus  infections  in  2009
as  compared  to 2010–2012  (0–3.8%).
Conclusion:  The  study  highlights  the  huge  burden  of rotavirus  disease  and  changing  proﬁle  of  circulating
rotavirus  strains  displaying  emergence  of G9P[4]  reassortant  strains  in  Pune,  western  India  and  empha-
sizes  the  need  to analyze  the entire  genomic  constellation  of rotavirus  strains  for better  evaluation  of the
impact  of  rotavirus.
©  2014  Published  by Elsevier  Ltd.  This  is an  open  access  article  under the  CC  BY-NC-ND  license. Introduction
Rotavirus is the prime cause of severe gastroenteritis in infants
nd young children worldwide, but developing countries are the
ost affected [1]. It is estimated that in India, rotavirus accounts
or 22% of the deaths, 30% of the hospitalizations and 8.3% of
he outpatient visits occurring globally each year [2]. In order to
ssess the need for and beneﬁts of currently available rotavirus
accines in India, the Indian Rotavirus Strain Surveillance Network
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(IRSN) operated by multiple centers has established foundation
of information on clinical, epidemiological and virological fea-
tures of rotavirus gastroenteritis from India [3]. The IRSN study
conducted during November 2005–June 2009 has shown a sig-
niﬁcant rotavirus disease burden and strain diversity in different
geographic regions of the country [4]. During 2005–2009, at the
Pune site, we  recorded a notable proportion of gastroenteritis infec-
tions caused by common (59.2%), uncommon (∼10%), emerging1
(9%) and mixed (15%) G(VP7) and P(VP4) rotavirus genotypes. To
better understand the rotavirus strain epidemiology and to explore
1 Emerging genotype is the one which is increasing in incidence or has the poten-
tial to increase in incidence.
Y-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
























































Rotavirus positivity in children with acute gastroenteritis in Pune, western India
(January 2009–December 2012).




(0.5%) and G1P[4] (0.5%) rotavirus strains. G1P[8] strains continued
to remain prevalent in all the years of study except the year 2009
in which G9P[8] strains (15.2%) were predominant. G9P[8] strains
remained second highest in the year 2010 and declined markedly
Table 2
Distribution of typed and untyped rotavirus strains detected in children with acute
gastroenteritis in Pune, western India (January 2009–December 2012).
Genotype category No. positive/No. tested (%)30 S.D. Chitambar et al. / V
ifferences in the proﬁle of rotavirus genotypes over a longer time
eriod, the surveillance study was continued from January 2009
o December 2012 in children <5 years, hospitalized for acute gas-
roenteritis – the results of which we report here.
. Methods
.1. Specimens and testing for rotavirus antigen
Stool specimens were collected from children aged <5 years,
ospitalized for acute gastroenteritis in three different hospitals
rom Pune city, western India. A case of acute gastroenteritis
nrolled in the present study was deﬁned as the passage of ≥3
oose or watery stools a day with or without associated symptoms
uch as vomiting, fever and abdominal pain. All the patients were
xamined for fever, number of episodes and duration of vomiting
nd diarrhea, extent of dehydration and treatment for the assess-
ent of severity of disease by 20-point scale of the Vesikari scoring
ystem [5]. The disease condition of each patient was  categorized
s mild (0–5), moderate (6–10), severe (11–15) and very severe
16–20). Epidemiologic data inclusive of age, dates of diarrhea onset
nd specimen collection, maximum number of episodes of diar-
hea and vomiting in a 24-h period were recorded for all patients.
he method employed for specimen collection was  approved by
he institutional human ethics committee. All the specimens were
ransported to the laboratory on wet ice and stored at +4 ◦C until
ested.
Ten percent (w/v) suspension of all of the stool specimens pre-
ared in 0.01 M phosphate buffered saline (PBS) (pH 7.2) were
ested for rotavirus A (RVA) antigen using a commercial ELISA kit
Generic Assays, Germany) as per the manufacturer’s instructions.
he specimens indicating optical density (O.D.) values above the
ut off value (0.2 + mean of OD values of negative control wells)
ere considered positive for rotavirus antigen. All specimens were
tored in aliquots at −70 ◦C for further testing.
.2. G- and P-typing
The viral nucleic acids were extracted from 30% (w/v) suspen-
ions of all ELISA positive stool specimens using Trizol (Invitrogen,
arlsbad, CA) as per the manufacturer’s instructions. The VP7 and
P4 genes were genotyped by multiplex reverse transcription
RT)-PCR according to the method described earlier with minor
odiﬁcations [6]. The viral RNA was subjected to one step RT-PCR
Qiagen, Hilden, Germany) using the sets of outer primers: 9Con1-
/VP7-R deg [7]; Con 3/Con 2 [8] and oligonucleotide primers that
ould amplify VP7 genotypes G1- G4, G8- G10 and G12 and VP4
enotypes P[4], P[6], P[8], P[9]; P[10] and P[11]. Brieﬂy, 4 l of ds
NA was denatured at 95 ◦C for 5 min  and then chilled in ice for
 min. A reaction mix  of 46 l containing 5Xbuffer, dNTPs, RNase-
ree water, primers 9Con1-L/Con3 and VP7-Rdeg/Con2 and 2 l
f enzyme mix  was added to make a ﬁnal volume of 50 l. All
CR products were analyzed by electrophoresis using Tris acetate
DTA (TAE) buffer, pH 8.3 on 2% agarose gels, containing ethid-
um bromide (0.5 g/ml) and visualized under UV illumination.
o determine the VP7 and VP4 genotypes of rotavirus strains
on-typeable in multiplex PCR, ﬁrst round PCR products obtained
n agarose gel electrophoresis were sequenced using ABI-PRISM
ig Dye Terminator Cycle Sequencing Kit (Applied Biosystems,
oster city, CA) and a ABI-PRISM 310 Genetic analyzer (Applied
iosystems) after puriﬁcation on minicolumns (QIAquick: Qiagen,
alencia, CA).2012 57/136 (41.9)b
a versus b: P < 0.05.
2.3. Statistical analysis
A comparison of meteorological data was carried out for differ-
ent years of the study using paired t-test. Two  proportions were
compared using chi square test. P-values <0.05 were considered
statistically signiﬁcant.
3. Results
We  collected a total of 685 stool specimens from children hospi-
talized for acute gastroenteritis during January 2009 to December
2012 in Pune, western India. Of these, 241 (35.1%) were positive for
rotavirus antigen by ELISA. Year wise analysis showed signiﬁcant
difference in the rotavirus positivity only between the years 2010
and 2012 (P < 0.05) but not in the other years (Table 1).
The mean age (± standard deviation) of children hospital-
ized with diarrhea was 15.8 ± 12.9 months. The mean age of
rotavirus infected children was 13.8 ± 9 months, which was signif-
icantly lower (P < 0.05) than that of rotavirus uninfected children
(16.8 ± 14.4 months). Among the rotavirus infected children, 58.5%
were in the age group of 7–12 months, while 14.5% belonged to ≤6
months.
Analysis of the clinical severity scores indicated very severe,
severe, moderate and mild disease in 2.8%, 56.5%, 38.7% and 2.3%
of the patients suffering for rotavirus gastroenteritis. As against
this, 5%, 47%, 38.3% and 7.7% of the patients tested negative for
rotavirus experienced very severe, severe, moderate and mild dis-
ease, respectively. In general, children with rotavirus diarrhea
had signiﬁcantly less mild and more severe disease than those
with rotavirus-negative diarrhea (P < 0.05). Rotavirus infected chil-
dren had more episodes of vomiting than did uninfected children
(P < 0.05).
The multiplex PCR conducted for genotyping of rotavirus strains
showed ampliﬁcation of VP7 and VP4 genes in 197 (81.7%) and 190
(78.8%) strains respectively and identiﬁed genotypes of both genes
in 178 (73.8%) strains (Table 2). 32 (13.2%) strains remained unty-
peable for both genes. We  detected infections with mixed rotavirus
strains in 18 (10.1%) of the 178 specimens.
Among the strains typed for both VP7 and VP4 genes, G1P[8]
strains attained the highest score (31.4%). This was followed by
G2P[4] (20.2%); G9P[8] (11.8%); G9P[4] (10.1%); G12P[6] (6.1%);
G12P[8] (3.3%); G2P[8] (2.8%); G2P[6] (2.2%); G3P[8] (0.5%); G4P[4]Typed for both G and P 178/241 (73.8)
Typed only for G 19/241 (7.8)
Typed only for P 12/241 (4.9)
Untyped for both 32/241 (13.2)
S.D. Chitambar et al. / Vaccine 32S (2014) A29–A32 A31
Table  3
Distribution of G and P typed rotavirus strains in children with acute gastroenteritis in Pune, western India (January 2009–December 2012).











No.  positive (%positivity)
Common
G1P[8] 5(8.5) 12(46.1) 19(39.6) 20(44.4) 56(31.4)
G2P[4] 6(10.2) 2(7.7) 14(29.2) 14(31.1) 36(20.2)
G3P[8] 1(1.7) – – – 1(0.5)
G9P[8] 9(15.3) 7(27) 4(8.3) 1(2.2) 21(11.8)
Rare
G1P[4] – 1(3.8) – – 1(0.5)
G2P[6] 2(3.4) – – 2(4.4) 4(2.2)
G2P[8] 5(8.5) – – – 5(2.8)
G4P[4] 1(1.7) – – – 1(0.5)
G9P[4] 2(3.4) 3(11.5) 9(18.7) 4(8.9) 18(10.1)
Emerging
G12P[8] 6(10.2) – – – 6(3.3)
G12P[6] 6(10.2) – 1(2) 4(8.9) 11(6.1)
Mixed∗ 16a((27.1) 1b((3.8) 1c(2) – 18(10.1)







































* Rotavirus genotypes in mixed infection.
n circulation in 2011–2012. We  found higher circulation of G9P[4]
trains, an unusual combination of G and P types in 2010–2012 as
ompared to 2009. Mixed infections were highest (27.1%) in the
ear 2009 and declined drastically in the following years (Table 3).
. Discussion
Two rotavirus vaccines, RotarixTM and RotaTeq® have been
icensed in ∼90 to 100 countries to use against rotavirus diarrhea.
oth vaccines are recommended by the World Health Organi-
ation (WHO) in childhood immunization programs conducted
lobally [9]. Studies report difference in the efﬁcacies of these
accines against severe rotavirus diarrhea in high and middle
ncome (85–98%) and low income (39–72%) countries [10]. In
ountries like India, where the vaccine efﬁcacy data is yet to be
cquired, monitoring of rotavirus disease and strains is essential
o assess the impact of rotavirus vaccines and circulating rotavirus
trains on each other. The data obtained in this direction in the
resent study reafﬁrm earlier reports (2005–2009) of the char-
cteristics of rotavirus infections, large rotavirus disease burden
nd strain diversity among children in Pune, western India [3,4].
ur data showed that rotavirus positivity continued to remain
igniﬁcant in each year of the study period (2009–2012) and con-
urred with recent study reports from India [11]. The frequency
f rotavirus infections was markedly higher in 2012 than in 2010
P < 0.05). We  analyzed these ﬁndings with respect to the meteo-
ological data obtained for both years. The mean values obtained
or relative humidity and temperature were signiﬁcantly lower in
012 (45.9% ± 21.7%, 17.8 ◦C ± 4.7 ◦C) than in 2010 (52.9% ± 21.6%,
9.4 ◦C ± 4.1 ◦C) (P = 0.004/0.0073) (Indian Meteorological Depart-
ent, Government of India, Pune). Our data indicated a deviation
f rotavirus infections toward lower humidity and temperature as
escribed previously in eastern India [12].
G1P[8], G2P[4], G3P[8], G4P[8] and G9P[8] are the most com-
on rotavirus strains circulating worldwide. Throughout the study
eriod, G1P[8] rotavirus strains showed highest prevalence, except
n the year 2009 where G9P[8] was the predominant strain.
lthough G2P[4] has been described as the second most predomi-
ant strain in other regions of India [4,13], we found variation in its
revalence in comparison with other commonly detected rotavirus
train, G9P[8]. An earlier study from Pune identiﬁed the G3P[8]strain once in the year 2005 [3] and was  detected only once in this
study. Other studies have documented the absence of this strain
and the G4P[8] strain indicating that they are uncommon in India.
Earlier rotavirus strain surveillance marked the circulation of
unusual combinations of G and P types (G1P[4], G1P[6], G2P[6],
G2P[8], G2P[10], G4P[4], G9P[4], G9P[6], G10P[6], G10P[8]) [3,4].
As against this, the present study detected only a limited num-
ber of such G-P combinations (G1P[4], G2P[6], G2P[8], G4P[4] and
G9P[4]) with a notable contribution of G9P[4] strains. The year
2009 witnessed the highest diversity in circulating rotavirus strains
in comparison with the years 2010–2012. Interestingly, the per-
centage of mixed infections was also highest (27.1%) in 2009 and
found to decline to 0% in 2012. Thus, the proportion of mixed infec-
tions of rotavirus may  correlate with the extent of diversity in
rotavirus strains. In the same year, G9P[8] strains which are con-
sidered the ﬁfth most common strains, displaced G1P[8] strains
known to be predominant globally. Subsequent to this, the preva-
lence of G9P[8] strains declined after attaining the highest score
in the year 2010. This was followed by a marked increase in the
circulation of rare G9P[4] strains. It is possible that the occurrence
of these strains could be a result of reassortment between G9P[8]
and G2P[4] strains. Generation of such a reassortment has been
proposed previously [14,15]. It is hypothesized that unusual com-
binations of G and P types are unﬁt for survival and hence do not
stabilize in the environment [16]. In view of this, the continuous
increase in the number of G9P[4] strains vis-a-vis a decrease in
G9P[8] strains identiﬁed in the present study needs to be moni-
tored further. Nevertheless, the data highlight the prominence of
G9 strains in the region and the importance of including the G9
component in the rotavirus vaccine. Such data would also support
the development of a designer vaccine for a speciﬁc region [17].
G12, known as the emerging genotype worldwide, detected earlier
in Pune at a signiﬁcant level (8.9%) [4] showed variability (0–10.2%)
in circulation during the period of present study.
Our study was  limited by the data from Pune city only. Hence,
the results presented here may  not be generalized to the rest of
India. Further, G and P-type could not be determined for about
13.2% of rotavirus positive specimens. Point mutations at the
primer binding site decrease the afﬁnity of primer binding and may
explain the failure to type such strains. This underscores a regu-
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ould also help conﬁrm the presence of ELISA reactive untypeable
otavirus strains.
To summarize, this study together with earlier studies that
escribe rotavirus epidemiology in Pune underlines the heavy bur-
en of rotavirus disease, the predominance of G1P[8] and G2P[4]
trains, the continued circulation of G9 strains with the emer-
ence of G9P[4] reassortant and G12 strains in Pune, western India.
hese ﬁndings evoke the need for further analysis of common, rare
nd emerging strains of rotaviruses at complete genome level to
etermine intergenogroup reassortments, emergence of unusual
ineages, antigenic drift and antigenic shift. Such studies will be use-
ul to understand the mechanisms of rotavirus strain diversity and
olecular evolution and most importantly in assessing the efﬁcacy
f rotavirus vaccines.
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